Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:11 AM
Ignite Modification Date:
2025-12-26 @ 11:11 AM
NCT ID:
NCT06806228
Eligibility Criteria:
Inclusion Criteria:
* confirmed diagnosis of Glioblastoma according to RANO criteria by contrast-enhanced MRI or PET-CT (including diffuse midline glioma, gliosarcoma or giant cell glioblastoma), relapse or disease progression
* patient is able to understand and give consent to participate in the study
* Karnofsky performance score ≥ 60
* women of childbearing potential must have a negative pregnancy test result no later than 7 days before registration
Exclusion Criteria:
* pregnant
* known allergies
* active treatment on annotner clinical trial
* inability to complete with protocol or studio procedures.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
99 Years
Study:
NCT06806228
Study Brief:
Protocol Section:
NCT06806228